Cargando…
Maculopapular rash after intravitreal injection of an antivascular endothelial growth factor, aflibercept, for treating age-related macular degeneration: A case report
RATIONALE: Aflibercept, an anti-vascular endothelial growth factor (VEGF) drug, is used for treatment of colon cancer as well as retinal diseases, including wet age-related macular degeneration (AMD). It is injected into the vitreous cavity of eyes for treatment of AMD. Although vascular suppression...
Autores principales: | Nagai, Norihiro, Ibuki, Mari, Shinoda, Hajime, Kameyama, Kaori, Tsubota, Kazuo, Ozawa, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457872/ https://www.ncbi.nlm.nih.gov/pubmed/28538392 http://dx.doi.org/10.1097/MD.0000000000006965 |
Ejemplares similares
-
Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice
por: Sato, Shinri, et al.
Publicado: (2017) -
Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment
por: Nagai, Norihiro, et al.
Publicado: (2016) -
Dynamic changes in neural retinal images during the development of a lamellar macular hole: A case report
por: Ozawa, Yoko, et al.
Publicado: (2019) -
Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
por: Suzuki, Misa, et al.
Publicado: (2014) -
Effects of intraocular treatments for Epstein-Barr virus (EBV) retinitis: A case report
por: Mushiga, Yasuaki, et al.
Publicado: (2021)